Fundraising Fox

CWRU Technology Ventures

Funding platform

Cleveland Β· Pre-Seed–Seed Β· 1 people tracked

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Technology commercialization arm of Case Western Reserve University that supports and spins out startups based on university research.

Source: firm website, verified Aug 3, 2026.

Stage
Pre-Seed–Seed
Check
$50K – $250K
HQ
Cleveland, Ohio, US
Instruments
Equity
Founded
2002
Tracked investments
40

Team Β· 1 people

from public directories

What they invest in

from 30 of 40 portfolio companies

Healthtech Γ—20Biotech Γ—18Medical Devices Γ—18Deep Tech Γ—8Digital Health Γ—6AI & Machine Learning Γ—4Data & Infrastructure Γ—3Cleantech Γ—2

HQs:United StatesΓ—21MexicoΓ—1

Who they back

founder profiles across 13 portfolio companies
38%
solo founders
5 of 13 mapped founding teams

Founding team size:solo founderΓ—52 foundersΓ—43 foundersΓ—4

Investments Β· 40 tracked

founders shown can be your intro path

By year:2022 Β· 22017 Β· 13 dated

Lucid Diagnosticsluciddx.comin𝕏NASDAQ: LUCD

Lucid Diagnostics develops tests for the early detection of esophageal precancer using targeted next-generation sequencing, aimed at helping clinicians detect and treat the condition before it progresses to cancer.

BiotechDigital HealthHealthtechMedical DevicesLake Forest, US

Michael A Gordon(Executive Officer)Shaun O'Neil(Executive Officer)inLishan Aklog(Chairman & CEO)inDennis McGrath(Executive Officer)inBrian deGuzman(Chief Technology Officer & Chief Compliance Officer)in

BoardDENNIS A. MATHEIS(Director)

NervGen Pharmanervgen.comin𝕏NASDAQ: NGEN

NervGen is a clinical-stage biotech company developing therapies for neurological conditions, with a focus on spinal cord injury and neurorepair.

BiotechDeep TechHealthtechMedical Devices

Dr. Jerry SilverHarold Punnett(Co-founder)inJerry Silver(Co-founder)William Adams(Executive Officer)Paul Brennan(Director, Executive Officer)Daniel Mikol(Executive Officer)

Co-investorsSCI Ventures

Afferenceafference.ioin𝕏

Afference develops neurotechnology that enables remote sensory perception through wearable devices, allowing people at a distance to share tactile sensations.

AI & Machine LearningDeep TechHardwareHealthtechCleveland, US

Jacob Segil(Co-founder & CEO)inDustin Tyler(Co-founder & CTO)in

BoardTaylor Hurst(Director)inTrevor Zimmerman(Director)in

Co-investorsAnthropy PartnersEvolution VC PartnersHannah Grey VenturesJobsOhio VenturesKonvoy VenturesMighty Capital+5 more

Alensia XRalensiaxr.comin𝕏

AlensiaXR develops holographic technology that replaces traditional cadavers in medical and dental education.

Deep TechEdTechHealthtech

Mark Day(Chief Executive Officer)in

Co-investorsJobsOhio VenturesJumpstart Ventures

Anemedsleepapnea.healthcare
Atelerix Life Sciencesatelerixlifesciences.cominSep 2022

Atelerix Life Sciences develops novel respiratory therapies for drug-induced respiratory depression, respiratory disease exacerbations, and bio-defense against respiratory threats.

BiotechHealthtechMedical DevicesIndianapolis, US

David Kalergis(Executive Officer, Director, Promoter)William Akridge(Director)

BoardPeter Barton Hutt(Director)

BioChip Labsbiochiplabs.comin

BioChip Labs provides laboratory testing services for blood disorders, including sickle cell disease and thalassemia, using traditional and proprietary blood cell analysis methods.

BiotechHealthtechMedical DevicesCleveland, US

BIOHMbiohmhealth.comin𝕏

BIOHM sells probiotic supplements and at-home gut test kits that analyze the microbiome, with results reviewed by a microbiome-trained registered nutritionist who provides personalized diet and supplement recommendations.

Digital HealthDirect to ConsumerWellness & FitnessCleveland, US

Mahmoud Ghannoum(Founder)Afif Ghannoum(Director)Sam Schatz(Executive Officer)Michael Haritakis(Executive Officer)Steven Himmel(Director)

BoardBob Pavey(Director)

Co-investorsJobsOhio VenturesJumpstart VenturesMiddleland Capital

BioVexin𝕏

Amgen is a biopharmaceutical company that develops and manufactures therapeutics targeting oncology, cardiovascular disease, inflammation, bone health, neuroscience, and other serious illnesses.

BiotechDigital HealthHealthtechMedical DevicesThousand Oaks, US

George B. Rathmann(First CEO)

BoardWilliam K. Bowes

Co-investorsAsset Management CompanyBOMMayfield FundUS Venture PartnersYsios Capital

Bisc Therapeuticsbisctherapeutics.com

Bisc Therapeutics develops Bax inhibitor therapies designed to prevent retinal cell death and preserve vision in patients with retinal degenerative diseases such as age-related macular degeneration, glaucoma, and inherited retinal disorders.

BiotechHealthtech

Collamedixbonezonepub.comin𝕏

BONEZONE is a media platform and conference brand serving orthopedic device manufacturers with editorial content, digital publications, and industry networking focused on product development, regulatory trends, and market intelligence.

Marketing TechMedia & EntertainmentMedical Devices

Convelo Therapeuticsconvelotx.comin𝕏

Convelo Therapeutics develops remyelination-enhancing therapies that target the central nervous system's myelination pathway to repair nerve damage in people with multiple sclerosis.

BiotechDeep TechHealthtechCleveland, US

Paul Tesar(Co-founder (Professor, PhD))inDrew Adams(Co-founder (Professor, PhD))Derrick Rossi(Leader/Executive)Tracy Saxton(Chief Operating Officer)Ed Mok(Head of Finance)Samantha Stubblefield(VP of Operations and Business Development)

Co-investorsJobsOhio VenturesJumpstart Ventures

COSMIICcosmiic.org

COSMIIC develops active implantable medical devices, including its Networked Neuroprosthesis (NNP) modular implant platform that stimulates muscles and records signals to restore function for people with disability and disease.

BiotechDeep TechHealthtechMedical DevicesCleveland, US

Edifice Analyticsedificeanalytics.com

Edifice Analytics provides software that quantifies energy and cost savings opportunities in commercial buildings using diagnostics, prognostics, and comparative analytics.

CleantechData & InfrastructureEnterprise SoftwareCleveland, US

Alexis Abramson(Co-founder / Senior Technical Advisor)Roger French(Co-founder / CTO)Dave Gordon(CEO)

Epix Therapeuticsin

Medtronic designs and develops medical technology for treating complex diseases.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Co-investors8VCElevate VenturesMenlo VenturesOak Investment PartnersPfizer Venture InvestmentsQuesta Capital+5 more

Folio Photonicsfoliophotonics.comin

Folio Photonics develops optical storage media using multi-layer read/write materials science to provide enterprise-scale, immutable active archive storage.

Data & InfrastructureDeep TechNew MaterialsSolon, US

Kenneth D. Singer(Executive Officer, Director)Steven J. Santamaria(Executive Officer, Director)Ronald B. Richard(Director)Robert D. Pavey(Director)Felix Brueck(Director)

Co-investorsJobsOhio VenturesMaterial ImpactRefinery VentureForte Ventures

Galvanixgalvanixmetals.comin

Galvanix develops a proprietary sustainable metal reduction process for producing rare earth permanent magnets, addressing the environmental concerns of China-dominated production methods and enabling domestic manufacturing.

Advanced ManufacturingCleantechNew Materials

Global Health Metricsglobalhealthmetrics.com

Global Health Metrics provides population health analytics and risk assessment tools for health plans, employers, and healthcare providers.

Data & InfrastructureEnterprise SoftwareHealthtech

Haimahaimatherapeutics.com

Haima Therapeutics is a pre-clinical stage biopharma company developing cell-inspired therapies for bleeding and blood-related diseases, with an initial focus on platelet-inspired treatments for active bleeding and bleeding risks from trauma, surgery, thrombocytopenia, and rare bleeding disorders.

BiotechMedical Devices

Anirban Sen Gupta(CTO)Michael Bruckman(CEO)Matthew Neal(CMO)Christa Pawlowski(COO and EVP of R&D)Timothy Pelura(Executive Chair)

Co-investorsTachyon Ventures

Hemex Healthhemexhealth.comin𝕏

Hemex Health develops and commercializes the Gazelle diagnostic platform, including point-of-care readers and tests for conditions such as sickle cell disease and hemoglobin variants.

Digital HealthHealthtechMedical DevicesPortland, US

Patricia White Seminario(Executive Officer, Director, Promoter)Peter Galen(Chief Innovation Officer, Co-Founder)Patti White(Chief Executive Officer, Co-Founder)Daren Bledsoe(Sr. VP, Engineering & Operations)inGerrit van Roekel(VP, Business Development)inUmut Gurkan(Chief Scientist, Microfluidics)in

Co-investorsPortland Seed FundElevate Capital

Intwine Connectintwineconnect.com
Lighthanded Enterpriseslight-handed.com

Light-Handed is developing diagnostic technology to improve the diagnosis of middle ear effusion (MEE), applying biomedical optics to medical device development.

Deep TechHardwareHealthtechMedical Devices

Steven Burns(Chief Executive Officer)inBrecken Blackburn(Chief Science Officer)inMatt McPheeters(Chief Technology Officer)in

Co-investorsJumpStart Equity

Luminary Therapeuticsluminarytx.com

BiotechHealthtechMedical DevicesMinneapolis, US

David Largaespada(Executive Officer, Director, Promoter)Jeff Liter(Executive Officer, Director, Promoter)James Haymaker(Director, Promoter)

BoardJeff Ross(Director)John Wells(Director)Tracey Lodie(Director)

Molecular Theranosticsmtheranostics.com𝕏

MT develops cancer-specific molecular imaging agents (probes) targeting a common oncoprotein in the tumor microenvironment, intended for use with imaging modalities such as CT, PET, MRI, SPECT and ultrasound.

BiotechHealthtechMedical DevicesOhio, US

Audrey Carballo

Neoindicateneoindicate.com

Neoindicate develops biomarkers and agents that target tumor microenvironments for cancer diagnosis, imaging, and treatment across multiple cancer types including brain tumors, melanoma, and breast cancer.

BiotechHealthtechMedical DevicesWellington, US

NeoProteomicsneoproteomics.net
Neuros Medicalneurosmedical.com

Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device that delivers patient-controlled electrical stimulation to treat chronic post-amputation pain in adult lower limb amputees.

BiotechHealthtechMedical DevicesAliso Viejo, US

David Veino(President and CEO)Zach Stassen(Chief Financial Officer)Robert J. Centa(Chief Financial Officer)Jon J. Snyder(Director, President, Secretary and CEO)

BoardJoyce Erony(Director)inWilliam Harrington(Director)

Co-investorsAmzak HealthAPERTURE Venture PartnersiSelect FundJobsOhio VenturesJumpstart VenturesRiverVest Venture Partners+5 more

OpsiClearopsiclear.com
Picture Healthpicturehealth.com

Picture Health develops AI tools that analyze routine radiology and pathology images to quantify biological properties of tumors for precision oncology.

AI & Machine LearningBiotechHealthtech

Co-investorsCintrifuse CapitalJobsOhio VenturesRefinery Venture

PolymerPlusacquired by Peaknano

Cleveland-based polymeric development company acquired by Peak Nanosystems for $25M in 2020.

Presidio Medicalpresidiomedical.com
RoadPrintzroadprintz.com
Rodeo TherapeuticsJul 2017

BiotechSeattle, US

Sanford Markowitz(Director)Thong Le(Executive Officer, Director, Promoter)David Schubert(Executive Officer, Promoter)James Sullivan(Director)Lindsay Rayle(Executive Officer, Promoter)Tadataka Yamada(Director)

Rora Biologicsrorabio.com

Co-investorsVentac Partners

SHC Therapeutics

Developing an HIV vaccine to allow patients treatment-free latency periods of 12-24 months.

Symphony Roboticssymphonyrobotics.health

Symphony Robotics develops investigational robotic technology for healthcare applications.

Medical DevicesRobotics

Synapse Biomedical Inc.synapsebiomedical.comDec 2022

Synapse Biomedical develops and commercializes neurostimulation medical devices, including the NeuRx Diaphragm Pacing System (DPS), which uses electrical stimulation of the diaphragm to treat chronic respiratory insufficiency in patients with spinal cord injuries and ALS.

BiotechDigital HealthHealthtechMedical DevicesHarrisburg, US

Anthony R Ignagni(Executive Officer, Director)Raymond P Onders(Director)Anthony R. Ignagni(Co-founder, President & CEO)Moustapha Diop(Chief Operating Officer)Kiyotaka Mori(Director)John Krystowski(Director)

Tevard Biosciencestevard.comin𝕏

Tevard Biosciences develops tRNA-based therapies to provide durable cures for rare genetic diseases caused by nonsense mutations, including cardiomyopathy, muscular dystrophy, and epilepsy.

BiotechBoston, US

Harvey LodishDaniel FischerWarren Lammert

Co-investorsGood Growth CapitalLauder Partners

Trailhead Biosystemstrailbio.comin

Trailhead Biosystems develops HD-DoE (High-Dimensional Design-of-Experiments), a platform that uses computational models and control systems to differentiate human induced pluripotent stem cells (iPSCs) into specific cell types for regenerative medicine and stem cell research.

AI & Machine LearningBiotechDeep TechMedical DevicesBeachwood, US

Jan Jensen(Founder)inJoshua Snow(Chief Commercial Officer)Divya Trivedi(Chief Operating Officer and Secretary)David Llewellyn(President & CEO)Josh Snow(Chief Commercial Officer)inJennifer Antonchuk(Vice President of Research and Development)in

XaTekclotchip.com

Exits Β· 3

IPOs and acquisitions across the tracked portfolio

Lucid DiagnosticsNASDAQ: LUCDNervGen PharmaNASDAQ: NGENPolymerPlusacq. by Peaknano

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has CWRU Technology Ventures made?
CWRU Technology Ventures has 40 tracked investments, 1 of which have exited via acquisition or IPO.
What stage does CWRU Technology Ventures invest at?
CWRU Technology Ventures invests at the Pre-Seed, Seed stages.
What is CWRU Technology Ventures's typical check size?
CWRU Technology Ventures typically writes checks of $50K – $250K.
What sectors does CWRU Technology Ventures focus on?
CWRU Technology Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is CWRU Technology Ventures located?
CWRU Technology Ventures is headquartered in Cleveland, US.
Who does CWRU Technology Ventures co-invest with?
CWRU Technology Ventures most often shares deals with JobsOhio Ventures, Jumpstart Ventures, Refinery Venture, among 41 tracked co-investors.

Images

CWRU Technology Ventures photo

Similar investors

Featured in lists